Prospector Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$656K Buy
9,385
+2,330
+33% +$163K 0.08% 85
2025
Q1
$519K Hold
7,055
0.06% 87
2024
Q4
$462K Hold
7,055
0.05% 91
2024
Q3
$550K Buy
7,055
+355
+5% +$27.7K 0.06% 91
2024
Q2
$523K Hold
6,700
0.06% 89
2024
Q1
$454K Buy
6,700
+370
+6% +$25.1K 0.05% 91
2023
Q4
$426K Buy
6,330
+445
+8% +$30K 0.05% 88
2023
Q3
$399K Hold
5,885
0.05% 87
2023
Q2
$421K Hold
5,885
0.06% 87
2023
Q1
$408K Hold
5,885
0.06% 91
2022
Q4
$399K Hold
5,885
0.05% 100
2022
Q3
$323K Hold
5,885
0.05% 100
2022
Q2
$389K Hold
5,885
0.06% 97
2022
Q1
$390K Sell
5,885
-175
-3% -$11.6K 0.05% 101
2021
Q4
$353K Hold
6,060
0.04% 106
2021
Q3
$364K Hold
6,060
0.05% 105
2021
Q2
$363K Hold
6,060
0.05% 107
2021
Q1
$301K Hold
6,060
0.04% 113
2020
Q4
$303K Sell
6,060
-27,250
-82% -$1.36M 0.04% 114
2020
Q3
$1.83M Sell
33,310
-850
-2% -$46.6K 0.27% 81
2020
Q2
$1.81M Buy
34,160
+2,650
+8% +$140K 0.31% 80
2020
Q1
$1.41M Sell
31,510
-490
-2% -$21.9K 0.27% 76
2019
Q4
$1.6M Hold
32,000
0.22% 86
2019
Q3
$1.43M Sell
32,000
-13,900
-30% -$619K 0.21% 90
2019
Q2
$1.9M Hold
45,900
0.26% 86
2019
Q1
$1.86M Sell
45,900
-13,900
-23% -$562K 0.28% 83
2018
Q4
$2.27M Hold
59,800
0.35% 77
2018
Q3
$2.37M Hold
59,800
0.33% 77
2018
Q2
$2.1M Hold
59,800
0.29% 86
2018
Q1
$2.09M Hold
59,800
0.31% 86
2017
Q4
$2.08M Hold
59,800
0.3% 84
2017
Q3
$2.03M Buy
59,800
+15,000
+33% +$508K 0.31% 84
2017
Q2
$1.53M Sell
44,800
-1,800
-4% -$61.4K 0.24% 91
2017
Q1
$1.45M Hold
46,600
0.22% 90
2016
Q4
$1.27M Hold
46,600
0.19% 93
2016
Q3
$1.53M Sell
46,600
-58,200
-56% -$1.91M 0.24% 90
2016
Q2
$3.16M Buy
104,800
+100
+0.1% +$3.02K 0.54% 67
2016
Q1
$2.95M Buy
104,700
+10,900
+12% +$307K 0.51% 68
2015
Q4
$3.19M Buy
+93,800
New +$3.19M 0.57% 64